| 000 | 01844cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030939.0 | ||
| 008 | 140308s2013 ua do f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2013.Sh.S | ||
| 100 | 0 | _aShaimaa Ali Abdelhalim Gad | |
| 245 | 1 | 0 |
_aStudy of the possible neuroprotective effect of certain drugs in experimentally induced hepatic encephalopathy in Rats / _cShaimaa Ali Abdelhalim Gad ; Supervised Sanaa A. Kenawy , Salwa H. Salama , Rania M. Abdelsalam |
| 246 | 1 | 5 | _aدراسة التأثير المحتمل لبعض الأدوية فى الإعتلال الدماغى الكبدى المحدث تجريبيا فى الجرذان |
| 260 |
_aCairo : _bShaimaa Ali Abdelhalim Gad , _c2013 |
||
| 300 |
_a169 P. : _bcharts , photographs ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aHepatic encephalopathy (HE) is a complex life-threatening neuropsychiatric syndrome that associated with acute or chronic liver failure. A spectrum of neurological symptoms and signs is observed in patients with HE. Hepatocytes injury, ammonia, oxidative stress and disturbed balance between excitatory and inhibitory neurotransmission are pathological factors that may be implicated in development of HE | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCerebrolysin | |
| 653 | 4 | _aHepatic encephalopathy | |
| 653 | 4 | _aTrimetazidine | |
| 700 | 0 |
_aRania Mohsen Abdelsalam , _eSupervisor |
|
| 700 | 0 |
_aSalwa Henry Salama , _eSupervisor |
|
| 700 | 0 |
_aSanaa Abdalbaky Kenawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c45270 _d45270 |
||